Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, is pleased to release its Appendix 4C - Quarterly Cashflow report and update for the quarter ended 31 December 2021.
In this Open Briefing(R), Bluechiip Limited (ASX:BCT) (FRA:1BL) MD Andrew McLellan discusses cash receipts from initial orders and deliveries of own product range, expectation for increasing revenues based on existing orders and growing enquiry pipeline, new patent award and developer kit sales and OEM negotiations.
Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, today announced the recent registration of Bluechiip s own branded cryovials with the United States.
In this Open Briefing(R) interview, Bluechiip Limited (ASX:BCT) (FRA:1BL) MD Andrew McLellan discusses the September quarter 4C, License and Development agreement with US-based Fujifilm Irvine Scientific and the first sales of Bluechiip s own consumables.